Clinical Trial Update: Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating everolimus in combination with cyclosporine microemulsion in de novo renal transplant recipients has completed, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Everolimus (everolimus)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Transplantation Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19